SYNERON MEDICAL LTD's ticker is ELOS and the CUSIP is M87245102. A total of 81 filers reported holding SYNERON MEDICAL LTD in Q2 2017. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $31,921,000 | -15.6% | 2,901,971 | -16.0% | 0.65% | +8.5% |
Q2 2017 | $37,833,000 | -2.6% | 3,455,097 | -6.1% | 0.60% | +3.6% |
Q1 2017 | $38,832,000 | +26.3% | 3,680,764 | +0.6% | 0.58% | +24.9% |
Q4 2016 | $30,749,000 | +25.8% | 3,660,613 | +7.2% | 0.46% | +25.9% |
Q3 2016 | $24,450,000 | +16.7% | 3,414,913 | +25.4% | 0.37% | +14.7% |
Q2 2016 | $20,944,000 | +14.2% | 2,723,535 | +8.5% | 0.32% | +22.1% |
Q1 2016 | $18,344,000 | +36.3% | 2,509,446 | +43.8% | 0.26% | +33.0% |
Q4 2015 | $13,459,000 | +230.0% | 1,745,669 | +206.1% | 0.20% | +228.3% |
Q3 2015 | $4,078,000 | -32.7% | 570,370 | -0.0% | 0.06% | -23.1% |
Q2 2015 | $6,058,000 | -43.5% | 570,430 | -34.2% | 0.08% | -47.3% |
Q1 2015 | $10,725,000 | -50.8% | 866,320 | -63.0% | 0.15% | -51.9% |
Q4 2014 | $21,818,000 | -5.3% | 2,338,530 | +1.7% | 0.31% | +0.7% |
Q3 2014 | $23,046,000 | +7.5% | 2,300,020 | +10.7% | 0.31% | +18.1% |
Q2 2014 | $21,442,000 | +9.4% | 2,077,630 | +31.9% | 0.26% | +4.9% |
Q1 2014 | $19,608,000 | -26.3% | 1,574,870 | -27.2% | 0.25% | -24.9% |
Q4 2013 | $26,619,000 | +75.0% | 2,164,137 | +22.6% | 0.33% | +67.9% |
Q3 2013 | $15,214,000 | +13.7% | 1,765,018 | +14.7% | 0.20% | +16.7% |
Q2 2013 | $13,384,000 | -8.2% | 1,538,349 | +7.8% | 0.17% | -2.3% |
Q1 2013 | $14,587,000 | +16.9% | 1,427,259 | -0.8% | 0.17% | +17.8% |
Q4 2012 | $12,475,000 | – | 1,438,789 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Acrospire Investment Management LLC | 2,738 | $30,000 | 90.91% |
BRANDES INVESTMENT PARTNERS, LP | 2,901,971 | $31,921,000 | 0.65% |
Lapides Asset Management, LLC | 186,200 | $2,044,000 | 0.42% |
GARDNER LEWIS ASSET MANAGEMENT L P | 51,703 | $569,000 | 0.04% |